Veratrak has announced that contract packaging organisation (CPO) Central Pharma has selected its platform to help it achieve digitised end-to-end visibility of its supply chain and improve collaboration.
The Veratrak platform provides companies with full transparency of their supply chains, ensures secure and compliant critical document transfer, as well as facilitating partner collaboration to drive operational performance.
Jason Lacombe, CEO at Veratrak said: “We are really pleased to be welcoming Central Pharma and their extensive customer and partner network to our platform.
“At present, all document approval and on-boarding processes at Central Pharma are running through email and internal working groups. By introducing our platform, we can help them to connect with their network, digitise these manual processes and secure their supply chain operations moving forward.”
Leveraging blockchain technology, the platform stores data as part of an immutable ledger and permits secure data sharing across supply chain partners.
By taking a proactive approach to cybersecurity, Veratrak has developed a system that generates an indisputable audit trail of all document processes and ensures GxP compliance.
Jason continued: “Our end goal is to move the industry from paper to platform and away from non-compliant methods, such as email. We are thrilled to be working with forward-thinking companies, such as Central Pharma to drive our industry towards a safer and more secure future.”
The Veratrak platform enables simple collaboration between multiple sites and across large customer networks. The data-driven methodology behind the platform also allows customers to access actionable insights, helping them to overcome operational inefficiencies they may not even be aware of.
Alwyn Smit, managing director at Central Pharma added: “By partnering with Veratrak we are taking the first step required to build a fully digital end-to-end supply chain network, that ensures data integrity and secure sharing of information between partners.
“We chose Veratrak because its platform was designed with the industry in mind. Its solution not only gives us control over our supply chain but also has the potential to add value to our operations. By using a collaborative platform that facilitates efficient workflow, we will be able to reduce lead times by improving order management.”
The Veratrak platform will be used across Central Pharma’s Bedford, UK site, with the aim of later being introduced to the CPO’s new site in Kerry, Ireland.
Alwyn continues: “As we supply products to over 60 countries and prepare to open our second site, Veratrak’s solution will help to ensure we continue to deliver high quality and on-time results for our customers. We are really excited about what this partnership will bring to both parties over the next year.”
The Veratrak platform is purpose-built for the life science industry and is being continuously developed by experts to provide a digital solution that solves unmet market challenges. The fast-growing company has recently doubled its team and onboarded other leading contract service providers to its platform.
Veratrak is a software provider for the life science industry which offers secure and compliant document transfer and facilitates collaboration between supply chain partners to generate efficiencies across operations. With the aim to move companies from paper to platform, its solution was developed by experts and aims to drive a digital transformation to create a safer, more secure future for the industry’s critical supply chains. Veratrak is supported by an advisory board with vast experience across the pharma industry, as well as insight into the supply chain, packaging, digital operations and new technologies. Co-founding members of the EPOCH initiative, the company is at the forefront of blockchain technology and its use in the pharmaceutical industry to benefit security, collaboration and operational performance.
About Central Pharma
Central Pharma is centrally located in Bedford, UK (46 miles north of London), close to all major transport links. Our services are vast and we are fully licensed to import products and release them to over 50 countries worldwide. This means we can provide regulatory support where needed. We operate an honest, ethical business with a high degree of integrity. Central Pharma invests in its people and in new technology to continually raise the bar on the level of care it provides. Every customer has a dedicated account manager. Leading the way is important to us and we believe that this is best achieved from the inside out. Always looking to advance further, we are currently actively pursuing World Class Manufacturing Status. Work with Central Pharma and you can expect flexibility, respect and excellence.
PLEASE NOTE: many 2020 events have been postponed / cancelled due to the worldwide COVID-19 Coronavirus pandemic. We recommend that you check directly with organisers to obtain the latest information on events of interest.
Global Brand Protection Innovation Programme, GBPIP 2020 (co-located with 3rd Global IT Security Summit)
May 14-15, 2020 - Brussels, Belgium
7th Brand Protection Excellence Forum (BPEF) 2020
June 04-05, 2020 - Munich, Germany
4th International Conference on Global Food Security
June 15-18, 2020 - Montpellier, France
4th GTDW Anti Illicit Trade & Brand Protection Technologies Conference
June 16-18, 2020 - Shanghai, China
Asia Security Conference & Exhibition
July 22-23, 2020 - Kuala Lumpur, Malaysia
International Food Fraud Conference
September 22-23, 2020 - Amsterdam, The Netherlands
Asian IP Forum (AIPF)
September 24-25, 2020 - Singapore
Global Brand Protection Summit 2020
September 24, 2020 - London, UK
European IP Forum
November 12-13, 2020 - Munich, Germany